NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|20129275|ref|NP_609022|]
View 

Neprilysin-like 5 [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
48-682 5.59e-85

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 280.41  E-value: 5.59e-85
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275  48 ARPCENFYQYACGNWQiqqqEQHSLRDRDWTRD-----RQRYQGQMLptdtlGLIDHSvnrklelllrrrneSSFESDSS 122
Cdd:cd08662   1 VDPCDDFYQYACGNWL----KNHPIPADKSSWGsfselQDRNEEQLR-----EILEEA--------------ASSAADSS 57
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 123 ILEQMRLYYRSCKRLKPYN------LKKYLQLLppsnstqwpsvgRGWRPERFDWITTLGRLRLHGLNGVLLREEVLPRW 196
Cdd:cd08662  58 AEQKAKDFYKSCMDEEAIEklglkpLKPLLDKI------------GGLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDP 125
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 197 DDSRNYSIYVNKPS---------RQETQPMGEGA----MIELLLDIGQTKRTANALARQVDDFERKLHRLQELEDDEGPR 263
Cdd:cd08662 126 KNSSRNILYLGQPGlglpdrdyyLDEENAEIREAykkyIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDP 205
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 264 -----EMQLGYLDSYLPQLRWLSFMRQVRIDSELDlrSTLIIENIPYLRALSDLMESESPDTVCSYIMLKWL-------- 330
Cdd:cd08662 206 ektynPLTLAELQKLAPSIDWKAYLKALGPPADDP--DKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLdslapyls 283
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 331 ------------AFLKQQGPADISRgECVAALRRAMPLASSWLVGQQFSDPESESYVSSLFQRLKVRFGQILAENRmRLS 398
Cdd:cd08662 284 kefrdarffygkALSGQKEPEPRWK-RCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLD-WMD 361
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 399 PPLVHILQQKLRAVRLQMGFfqTEEIED---VEQYHVRIDLSGhSFYGNQLVLLRQRVEANHDLLYINVTnfanstgsnl 475
Cdd:cd08662 362 EETKKKALEKLDAMKVKIGY--PDKWRDysaLDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKPVD---------- 428
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 476 sylSESWEASNSS--PLYVRPRNLVLVPHGLLQLPIWHRNISALQQHAVMGFVLAHELAHGFDMLGMDYDAMGNiMGPVE 553
Cdd:cd08662 429 ---RTEWSMSPQTvnAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGN-LRNWW 504
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 554 EIGASRQFRQGLQCLQQQMAT----------GSKWIDEKLADFVALRLAYETFFGVRDKREPRDPLLPQFSQRQLFFITF 623
Cdd:cd08662 505 TNEDRKEFEERAQCLVDQYSNyevppglhvnGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSF 584
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*....
gi 20129275 624 AQFFCGRTPVLSPRSQSeAHLKHAADELRVMQTLANFEEFSREFGCDKKAKMQASQRCR 682
Cdd:cd08662 585 AQVWCSKYRPEALRQLL-LTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
48-682 5.59e-85

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 280.41  E-value: 5.59e-85
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275  48 ARPCENFYQYACGNWQiqqqEQHSLRDRDWTRD-----RQRYQGQMLptdtlGLIDHSvnrklelllrrrneSSFESDSS 122
Cdd:cd08662   1 VDPCDDFYQYACGNWL----KNHPIPADKSSWGsfselQDRNEEQLR-----EILEEA--------------ASSAADSS 57
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 123 ILEQMRLYYRSCKRLKPYN------LKKYLQLLppsnstqwpsvgRGWRPERFDWITTLGRLRLHGLNGVLLREEVLPRW 196
Cdd:cd08662  58 AEQKAKDFYKSCMDEEAIEklglkpLKPLLDKI------------GGLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDP 125
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 197 DDSRNYSIYVNKPS---------RQETQPMGEGA----MIELLLDIGQTKRTANALARQVDDFERKLHRLQELEDDEGPR 263
Cdd:cd08662 126 KNSSRNILYLGQPGlglpdrdyyLDEENAEIREAykkyIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDP 205
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 264 -----EMQLGYLDSYLPQLRWLSFMRQVRIDSELDlrSTLIIENIPYLRALSDLMESESPDTVCSYIMLKWL-------- 330
Cdd:cd08662 206 ektynPLTLAELQKLAPSIDWKAYLKALGPPADDP--DKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLdslapyls 283
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 331 ------------AFLKQQGPADISRgECVAALRRAMPLASSWLVGQQFSDPESESYVSSLFQRLKVRFGQILAENRmRLS 398
Cdd:cd08662 284 kefrdarffygkALSGQKEPEPRWK-RCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLD-WMD 361
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 399 PPLVHILQQKLRAVRLQMGFfqTEEIED---VEQYHVRIDLSGhSFYGNQLVLLRQRVEANHDLLYINVTnfanstgsnl 475
Cdd:cd08662 362 EETKKKALEKLDAMKVKIGY--PDKWRDysaLDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKPVD---------- 428
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 476 sylSESWEASNSS--PLYVRPRNLVLVPHGLLQLPIWHRNISALQQHAVMGFVLAHELAHGFDMLGMDYDAMGNiMGPVE 553
Cdd:cd08662 429 ---RTEWSMSPQTvnAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGN-LRNWW 504
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 554 EIGASRQFRQGLQCLQQQMAT----------GSKWIDEKLADFVALRLAYETFFGVRDKREPRDPLLPQFSQRQLFFITF 623
Cdd:cd08662 505 TNEDRKEFEERAQCLVDQYSNyevppglhvnGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSF 584
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*....
gi 20129275 624 AQFFCGRTPVLSPRSQSeAHLKHAADELRVMQTLANFEEFSREFGCDKKAKMQASQRCR 682
Cdd:cd08662 585 AQVWCSKYRPEALRQLL-LTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
491-683 2.78e-32

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 124.06  E-value: 2.78e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   491 YVRPRNLVLVPHGLLQLPIWHRNISALQQHAVMGFVLAHELAHGFDMLGMDYDAMGNIMGPVEEIGASrQFRQGLQCLQQ 570
Cdd:pfam01431   4 YQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAE-EFKDRAQCLIE 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   571 QMAT-----------GSKWIDEKLADFVALRLAYETFFGVRDKREPRDPLLPQFSQRQLFFITFAQFFCGRtpvlspRSQ 639
Cdd:pfam01431  83 QYSEytppdgtkcanGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMK------QSP 156
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 20129275   640 SEAHLK-----HAADELRVMQTLANFEEFSREFGCDKKAKMQASQRCRI 683
Cdd:pfam01431 157 AEVLRQllvdpHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
1-684 1.62e-13

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 74.03  E-value: 1.62e-13
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   1 MLKLSLVAWLIFSLAwrttptACRQTNAPQSVQEMLAeqlqsYMDTKARPCENFYQYACGNW----QIQQQE-----QHS 71
Cdd:COG3590   1 MKKLLLLLALLLALA------ACAAAAAAGTSGIDLA-----NMDTSVRPGDDFYRYVNGGWlkttPIPADRsrwgsFNE 69
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275  72 LRDRdwTRDRQRyqgqmlptdtlGLIDHSVnrklelllrrrneSSFESDSSILEQMRLYYRSC--------KRLKPynLK 143
Cdd:COG3590  70 LRER--NEARLR-----------AILEEAA-------------AAPAAAGSDEQKIGDLYASFmdeaaieaLGLAP--LK 121
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 144 KYLqllppsnstqwpsvgrgwrpERFDWITT-------LGRLRLHGLNGvLLREEVLPRWDDSRNYSIYVNK-----PSR 211
Cdd:COG3590 122 PDL--------------------ARIDAIKDkadlaalLAALHRAGVGG-LFGFGVDADLKNSTRYIAYLGQgglglPDR 180
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 212 ---QETQPMGEG------AMIELLLD-IGQTKRTANALARQVDDFERKLHRLQ-ELEDDegpREMQLGY-------LDSY 273
Cdd:COG3590 181 dyyLKDDEKSAEiraayvAHVAKMLElAGYDEADAAAAAEAVLALETALAKAHwSRVEL---RDPEKTYnpmtvaeLAKL 257
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 274 LPQLRWLSFMRQVRIDSEldlrSTLIIENIPYLRALSDLMESESPDTVCSYimLKW----------------LAF----- 332
Cdd:COG3590 258 APGFDWDAYLKALGLPAV----DEVIVGQPSFFKALDKLLASTPLEDWKAY--LRWhlldsaapylskafvdANFdfygk 331
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 333 ----LKQQGPadisRGE-CVAALRRAMplasSWLVGQQ-----FSdPESESYVSSLFQRLKVRFGQILAEN-RMrlSPPL 401
Cdd:COG3590 332 tlsgQKEQRP----RWKrAVALVNGAL----GEALGQLyveryFP-PEAKARMEELVANLRAAYRERIENLdWM--SPET 400
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 402 VHILQQKLRAVRLQMGFfqTEEIEDVEQYHVRIDlsghSFYGNqlvLLR-QRVEANHDLLYIN--------------Vtn 466
Cdd:COG3590 401 KAKALEKLAAFTPKIGY--PDKWRDYSGLEIKRD----DLVGN---VLRaSAFEYQRELAKLGkpvdrtewgmtpqtV-- 469
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 467 fanstgsNLSYlsesweasnsSPLyvrpRNLVLVPHGLLQLPIWHRNISAlqqhAV----MGFVLAHELAHGFDMLGMDY 542
Cdd:COG3590 470 -------NAYY----------NPT----MNEIVFPAAILQPPFFDPKADD----AVnyggIGAVIGHEITHGFDDQGSQF 524
                       650       660       670       680       690       700       710       720
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 543 DAMGNImgpveeigasR---------QFRQGLQCLQQQMAT----------GSKWIDEKLADFVALRLAYETFFGVRDKR 603
Cdd:COG3590 525 DGDGNL----------RnwwtpedraAFEARTKKLVAQYDAyeplpglhvnGKLTLGENIADLGGLSIAYDAYKLSLKGK 594
                       730       740       750       760       770       780       790       800
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 604 EPrdPLLPQFSQRQLFFITFAQFFCGRTpvlsprsqSEAHLK-------HAADELRVMQTLANFEEFSREFGCDKKAKM- 675
Cdd:COG3590 595 EA--PVIDGFTGDQRFFLGWAQVWRSKA--------RDEALRqrlatdpHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMy 664
                       810
                ....*....|
gi 20129275 676 -QASQRCRIW 684
Cdd:COG3590 665 lAPEDRVRIW 674
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
48-682 5.59e-85

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 280.41  E-value: 5.59e-85
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275  48 ARPCENFYQYACGNWQiqqqEQHSLRDRDWTRD-----RQRYQGQMLptdtlGLIDHSvnrklelllrrrneSSFESDSS 122
Cdd:cd08662   1 VDPCDDFYQYACGNWL----KNHPIPADKSSWGsfselQDRNEEQLR-----EILEEA--------------ASSAADSS 57
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 123 ILEQMRLYYRSCKRLKPYN------LKKYLQLLppsnstqwpsvgRGWRPERFDWITTLGRLRLHGLNGVLLREEVLPRW 196
Cdd:cd08662  58 AEQKAKDFYKSCMDEEAIEklglkpLKPLLDKI------------GGLPSLDDLAAELLLALLRRLGVSLLFGLGVSPDP 125
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 197 DDSRNYSIYVNKPS---------RQETQPMGEGA----MIELLLDIGQTKRTANALARQVDDFERKLHRLQELEDDEGPR 263
Cdd:cd08662 126 KNSSRNILYLGQPGlglpdrdyyLDEENAEIREAykkyIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDP 205
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 264 -----EMQLGYLDSYLPQLRWLSFMRQVRIDSELDlrSTLIIENIPYLRALSDLMESESPDTVCSYIMLKWL-------- 330
Cdd:cd08662 206 ektynPLTLAELQKLAPSIDWKAYLKALGPPADDP--DKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLdslapyls 283
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 331 ------------AFLKQQGPADISRgECVAALRRAMPLASSWLVGQQFSDPESESYVSSLFQRLKVRFGQILAENRmRLS 398
Cdd:cd08662 284 kefrdarffygkALSGQKEPEPRWK-RCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIKEAFKERLENLD-WMD 361
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 399 PPLVHILQQKLRAVRLQMGFfqTEEIED---VEQYHVRIDLSGhSFYGNQLVLLRQRVEANHDLLYINVTnfanstgsnl 475
Cdd:cd08662 362 EETKKKALEKLDAMKVKIGY--PDKWRDysaLDIYYDDLNVSD-SYFENVLRLLRFETKRQLAKLGKPVD---------- 428
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 476 sylSESWEASNSS--PLYVRPRNLVLVPHGLLQLPIWHRNISALQQHAVMGFVLAHELAHGFDMLGMDYDAMGNiMGPVE 553
Cdd:cd08662 429 ---RTEWSMSPQTvnAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGN-LRNWW 504
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 554 EIGASRQFRQGLQCLQQQMAT----------GSKWIDEKLADFVALRLAYETFFGVRDKREPRDPLLPQFSQRQLFFITF 623
Cdd:cd08662 505 TNEDRKEFEERAQCLVDQYSNyevppglhvnGKLTLGENIADNGGLRLAYRAYKKWLKENGPELPGLEGFTPEQLFFLSF 584
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*....
gi 20129275 624 AQFFCGRTPVLSPRSQSeAHLKHAADELRVMQTLANFEEFSREFGCDKKAKMQASQRCR 682
Cdd:cd08662 585 AQVWCSKYRPEALRQLL-LTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
491-683 2.78e-32

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 124.06  E-value: 2.78e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   491 YVRPRNLVLVPHGLLQLPIWHRNISALQQHAVMGFVLAHELAHGFDMLGMDYDAMGNIMGPVEEIGASrQFRQGLQCLQQ 570
Cdd:pfam01431   4 YQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAE-EFKDRAQCLIE 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   571 QMAT-----------GSKWIDEKLADFVALRLAYETFFGVRDKREPRDPLLPQFSQRQLFFITFAQFFCGRtpvlspRSQ 639
Cdd:pfam01431  83 QYSEytppdgtkcanGTLTLGENIADLGGLTIALRAYKKLLSANETVLPGFENLTPDQLFFRGAAQIWCMK------QSP 156
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*....
gi 20129275   640 SEAHLK-----HAADELRVMQTLANFEEFSREFGCDKKAKMQASQRCRI 683
Cdd:pfam01431 157 AEVLRQllvdpHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
50-418 3.88e-27

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 113.93  E-value: 3.88e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275    50 PCENFYQYACGNWqiqqQEQHSLRDrdwtrDRQRYqgqmlptDTLGLIDHSVNRKLELLLRRRNESSFESDSSilEQMRL 129
Cdd:pfam05649   1 PCDDFYQYACGGW----LKNHPIPA-----DKSSW-------GTFDELRERNEKQLREILEEAAASESDPGAV--EKAKD 62
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   130 YYRSC--------KRLKPynLKKYLQLLPpsnstqwpsvGRGWRPERFDWITTLGRLRLHGLNGvLLREEVLPRWDDSRN 201
Cdd:pfam05649  63 LYKSCmdtdaiekLGLKP--LKPLLDEIG----------GPLANKDKFDLLETLAKLRRYGVDS-LFGFGVGPDDKNSSR 129
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   202 YSIYVNK-----PSR----QETQPMGEG------AMIELLLDIGQTKRTANALARQVDDFERKLHRLQELEDDEGPRE-- 264
Cdd:pfam05649 130 NILYLDQpglglPDRdyylKDRDEKSAEireaykAYIAKLLTLLGASEEAAALAEEVLAFETKLAKASLSREERRDPEkt 209
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   265 ---MQLGYLDSYLPQLRWLSFMRQVRIDSELDlrSTLIIENIPYLRALSDLMESESPDTVCSYIMLKWL----------- 330
Cdd:pfam05649 210 ynpMTLAELQKLAPGIDWKAYLNAAGLPDVPS--DEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVrslapylsdef 287
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   331 -----AFLKQ-QGPADISRGE-CVAALRRAMPLASSWLVGQQFSDPESESYVSSLFQRLKVRFGQILAENRMrLSPPLVH 403
Cdd:pfam05649 288 rdanfEFYGTlSGTKQRPRWKrCVSLVNGLLGEALGRLYVKKYFPEEAKARVEELVENIKEAFRERLDELDW-MDEETKK 366
                         410
                  ....*....|....*
gi 20129275   404 ILQQKLRAVRLQMGF 418
Cdd:pfam05649 367 KALEKLDAMTVKIGY 381
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
1-684 1.62e-13

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 74.03  E-value: 1.62e-13
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275   1 MLKLSLVAWLIFSLAwrttptACRQTNAPQSVQEMLAeqlqsYMDTKARPCENFYQYACGNW----QIQQQE-----QHS 71
Cdd:COG3590   1 MKKLLLLLALLLALA------ACAAAAAAGTSGIDLA-----NMDTSVRPGDDFYRYVNGGWlkttPIPADRsrwgsFNE 69
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275  72 LRDRdwTRDRQRyqgqmlptdtlGLIDHSVnrklelllrrrneSSFESDSSILEQMRLYYRSC--------KRLKPynLK 143
Cdd:COG3590  70 LRER--NEARLR-----------AILEEAA-------------AAPAAAGSDEQKIGDLYASFmdeaaieaLGLAP--LK 121
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 144 KYLqllppsnstqwpsvgrgwrpERFDWITT-------LGRLRLHGLNGvLLREEVLPRWDDSRNYSIYVNK-----PSR 211
Cdd:COG3590 122 PDL--------------------ARIDAIKDkadlaalLAALHRAGVGG-LFGFGVDADLKNSTRYIAYLGQgglglPDR 180
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 212 ---QETQPMGEG------AMIELLLD-IGQTKRTANALARQVDDFERKLHRLQ-ELEDDegpREMQLGY-------LDSY 273
Cdd:COG3590 181 dyyLKDDEKSAEiraayvAHVAKMLElAGYDEADAAAAAEAVLALETALAKAHwSRVEL---RDPEKTYnpmtvaeLAKL 257
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 274 LPQLRWLSFMRQVRIDSEldlrSTLIIENIPYLRALSDLMESESPDTVCSYimLKW----------------LAF----- 332
Cdd:COG3590 258 APGFDWDAYLKALGLPAV----DEVIVGQPSFFKALDKLLASTPLEDWKAY--LRWhlldsaapylskafvdANFdfygk 331
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 333 ----LKQQGPadisRGE-CVAALRRAMplasSWLVGQQ-----FSdPESESYVSSLFQRLKVRFGQILAEN-RMrlSPPL 401
Cdd:COG3590 332 tlsgQKEQRP----RWKrAVALVNGAL----GEALGQLyveryFP-PEAKARMEELVANLRAAYRERIENLdWM--SPET 400
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 402 VHILQQKLRAVRLQMGFfqTEEIEDVEQYHVRIDlsghSFYGNqlvLLR-QRVEANHDLLYIN--------------Vtn 466
Cdd:COG3590 401 KAKALEKLAAFTPKIGY--PDKWRDYSGLEIKRD----DLVGN---VLRaSAFEYQRELAKLGkpvdrtewgmtpqtV-- 469
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 467 fanstgsNLSYlsesweasnsSPLyvrpRNLVLVPHGLLQLPIWHRNISAlqqhAV----MGFVLAHELAHGFDMLGMDY 542
Cdd:COG3590 470 -------NAYY----------NPT----MNEIVFPAAILQPPFFDPKADD----AVnyggIGAVIGHEITHGFDDQGSQF 524
                       650       660       670       680       690       700       710       720
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 543 DAMGNImgpveeigasR---------QFRQGLQCLQQQMAT----------GSKWIDEKLADFVALRLAYETFFGVRDKR 603
Cdd:COG3590 525 DGDGNL----------RnwwtpedraAFEARTKKLVAQYDAyeplpglhvnGKLTLGENIADLGGLSIAYDAYKLSLKGK 594
                       730       740       750       760       770       780       790       800
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 20129275 604 EPrdPLLPQFSQRQLFFITFAQFFCGRTpvlsprsqSEAHLK-------HAADELRVMQTLANFEEFSREFGCDKKAKM- 675
Cdd:COG3590 595 EA--PVIDGFTGDQRFFLGWAQVWRSKA--------RDEALRqrlatdpHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMy 664
                       810
                ....*....|
gi 20129275 676 -QASQRCRIW 684
Cdd:COG3590 665 lAPEDRVRIW 674
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH